Name

Toca 511

Alternate Names

Toca FC

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

None

NSC Number

None

Primary Site

Brain

Histology

Glioblastoma, anaplastic astrocytoma

Remarks

July 19, 2015: U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Toca 511 & Toca FC, for the treatment of recurrent high grade glioma, which includes glioblastoma and anaplastic astrocytoma. This drug has not yet received final approval. code as Other Treatment and assign code 2.

Coding

Please see remarks for additional information
Glossary